Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:43 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,777,942 8.900% | -682,148 (-8.06%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | MAVERICK CAPITAL LTD | 25,028,128 3.800% | -8,699,656 (-25.79%) | Filing History |
| 2025-01-21 8:33 pm Sale | 2025-01-16 | 13D | Verona Pharma plc VRNA | Growth Equity Opportunities Fund IV, LLC | 32,679,649 4.990% | -11,998,376 (-26.86%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 8,460,090 9.990% | 956,114 (+12.74%) | Filing History |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 6,565,933 8.100% | 1,447,788 (+28.29%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | MAVERICK CAPITAL LTD | 33,727,784 5.200% | 33,727,784 (New Position) | Filing History |
| 2024-11-14 09:47 am Sale | 2024-09-30 | 13G | Verona Pharma plc VRNA | Deep Track Capital LP | 25,440,200 3.910% | -7,492,192 (-22.75%) | Filing History |
| 2024-11-13 8:46 pm Sale | 2024-09-30 | 13G | Verona Pharma plc VRNA | VIVO VENTURES VII LLC | 20,252,688 3.100% | -2,889,512 (-12.49%) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Verona Pharma plc VRNA | FMR LLC | 5,732,704 0.883% | -33,486,312 (-85.38%) | Filing History |
| 2024-08-28 9:51 pm Sale | 2022-09-07 | 13D | Verona Pharma plc VRNA | Growth Equity Opportunities Fund IV, LLC | 44,678,025 6.900% | -1,769,626 (-3.81%) | Filing History |
| 2024-07-29 9:43 pm Purchase | 2024-07-17 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 5,118,145 6.300% | 1,251,931 (+32.38%) | Filing History |
| 2024-07-12 4:04 pm Purchase | 2024-07-03 | 13G | Verona Pharma plc VRNA | Deep Track Capital LP | 32,932,392 5.080% | 32,932,392 (New Position) | Filing History |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,503,976 9.990% | -188,014 (-2.44%) | Filing History |
| 2024-02-14 4:27 pm Sale | 2023-12-31 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 3,866,214 4.800% | -596,452 (-13.37%) | Filing History |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | Verona Pharma plc VRNA | FMR LLC | 39,219,016 6.167% | 39,219,016 (New Position) | Filing History |
| 2024-02-08 10:03 am Sale | 2023-12-29 | 13G | Verona Pharma plc VRNA | WELLINGTON MANAGEMENT CO LLP | 30,271,952 4.730% | -8,383,952 (-21.69%) | Filing History |
| 2023-05-16 4:25 pm Sale | 2023-05-15 | 13D | Verona Pharma plc VRNA | ORBIMED ADVISORS LLC | 3,777,778 4.800% | -482,913 (-11.33%) | Filing History |
| 2023-04-25 4:16 pm Sale | 2023-04-18 | 13G | Verona Pharma plc VRNA | Access Industries Holdings LLC | 0 0.000% | -32,946,296 (Position Closed) | Filing History |
| 2023-04-20 5:01 pm Purchase | 2023-04-18 | 13G | Verona Pharma plc VRNA | PERCEPTIVE ADVISORS LLC | 4,462,666 5.600% | 4,462,666 (New Position) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT LLC | 7,691,990 9.990% | -41,086,182 (-84.23%) | Filing History |